Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Mitoxantrone Hydrochloride for Injection

Approval Number

国药准字H20057796

Company海南先声再明医药股份有限公司

Registration Date

July 7, 2020

Drug Information

Generic Name

注射用盐酸米托蒽醌

Dosage Form

注射剂

Strength

5mg(以C₂₂H₂₈N₄O₆计)

Drug Type

化学药品

Registration Date

July 7, 2020

Company Information

Applicant Company

Company Name海南先声再明医药股份有限公司

Company Address

海南省海口市秀英区药谷一横路20号

Manufacturing Company

Company Name海南先声药业有限公司

Company Address

江苏省南京江北新区华康路99号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用盐酸米托蒽醌 - NMPA 批准文号 | MedPath